Small Pharma to Present at Cowen’s 43rd Annual Health Care Conference
March 01, 2023 at 07:50 AM EST
LONDON, March 01, 2023 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the “Company” or “Small Pharma”), a biotechnology company focused on short-duration psychedelic-assisted therapies for mental health conditions, is pleased to announce that George Tziras, Chief Executive Officer and Dr. Carol Routledge, Chief Medical and Scientific Officer, will participate in Cowen’s 43rd Annual Health Care Conference, taking place on March 6 - 8, 2023 at the Boston Marriott Copley Place.
Small Pharma will also host a cocktail reception with guest speaker Jerry Rosenbaum, MD, Stanley Cobb Professor of Psychiatry at Harvard Medical School, and Director of the Massachusetts General Hospital Center for Neuroscience of Psychedelics.
Details of the Company’s presentation and cocktail reception are as follows:
To schedule a one-on-one meeting with Small Pharma’s management team, please contact email@example.com.
Cocktail Reception (3-minute walk from conference venue)
About Small Pharma
For further information contact:
Small Pharma Inc.
Investor Relations Contacts:
Media Relations Contacts:
The TSX Venture Exchange (“TSXV”) has neither approved nor disapproved the contents of this news release. Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.